H. Sörensen

4.0k citations

25 papers · 2.9k indexed · 1 hit paper · h-index 17

Rheumatology top 0.2%
Immunology top 2%
Hematology top 1%
Genetics top 10%
Epidemiology

Co-authors: Joachim Sieper Joachim Listing J. Brandt Jürgen Braun H. Kellner Rieke Alten A. Zink H. Zeidler
Topics: Rheumatoid Arthritis Research and Therapies (16 papers)Spondyloarthritis Studies and Treatments (14 papers)Autoimmune and Inflammatory Disorders Research (5 papers)
Cited by: Rheumatology Hematology Immunology
Journals: The Lancet Journal of the American Geriatrics Society Annals of the Rheumatic Diseases
Partner nations: Germany Denmark United States

In The Last Decade

H. Sörensen

25 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

2002 953 citations Jürgen Braun, J. Brandt et al. The Lancet profile →

Peers

Countries citing papers authored by H. Sörensen

Since Specialization

Citations

This map shows the geographic impact of H. Sörensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Sörensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Sörensen more than expected).

Fields of papers citing papers by H. Sörensen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Sörensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Sörensen. The network helps show where H. Sörensen may publish in the future.

Co-authorship network of co-authors of H. Sörensen

This figure shows the co-authorship network connecting the top 25 collaborators of H. Sörensen. A scholar is included among the top collaborators of H. Sörensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Sörensen. H. Sörensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Using a Patient-Reported Outcome Measure to Assess Physical, Psychosocial, and Existential Issues in COPD 2024 ·Journal of Clinical Medicine ·H. Sörensen,(unknown),Anders Løkke,(unknown),(unknown),(unknown),Ingeborg Farver-Vestergaard	1
2	Rituximab in patients with rheumatoid arthritis in routine practice (GERINIS): six-year results from a prospective, multicentre, non-interventional study in 2,484 patients 2014 ·Arthritis Research & Therapy ·J. Wendler,Gerd R Burmester,H. Sörensen,Andreas Krause,(unknown),Hans‐Peter Tony,Andrea Rubbert‐Roth,Peter Bartz‐Bazzanella,Siegfried Wassenberg,(unknown),Thomas Dörner	44
3	Evaluation of a novel 7‐joint ultrasound score in daily rheumatologic practice: A pilot project 2009 ·Arthritis Care & Research ·M. Backhaus,Sarah Ohrndorf,H. Kellner,Johannes Strunk,Tina Backhaus,Wolfgang Hartung,Horst Sattler,Katinka Albrecht,Jörg Kaufmann,Karsten Becker,H. Sörensen,(unknown),G.-R. Burmester,Wolfgang Schmidt	318
4	Rose hip herbal remedy in patients with rheumatoid arthritis – a randomised controlled trial 2009 ·Phytomedicine ·Stefan N. Willich,Karin Rossnagel,Stephanie Roll,(unknown),(unknown),(unknown),A. Kharazmi,H. Sörensen,K. Winther	69
5	Safety and efficacy of readministration of infliximab after longterm continuous therapy and withdrawal in patients with ankylosing spondylitis. 2007 ·PubMed ·Xenofon Baraliakos,Joachim Listing,Martín Rudwaleit,J. Brandt,Rieke Alten,Gerd R Burmester,Erika Gromnica‐Ihle,Hildrun Haibel,(unknown),Matthias Schneider,H. Sörensen,H. Zeidler,Sudha Visvanathan,Joachim Sieper,Juergen Braun	50
6	Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: Clinical and magnetic resonance imaging data 2005 ·Arthritis Care & Research ·Xenofon Baraliakos,J. Brandt,Joachim Listing,Hildrun Haibel,H. Sörensen,Martín Rudwaleit,Joachim Sieper,Jürgen Braun	128
7	Persistent clinical response to the anti-TNF-α antibody infliximab in patients with ankylosing spondylitis over 3 years 2005 ·Lara D. Veeken ·Joseph M. Braun,Xenofon Baraliakos,J. Brandt,Joachim Listing,A. Zink,Rieke Alten,Gerd R Burmester,Erika Gromnica‐Ihle,H. Kellner,Matthias Schneider,H. Sörensen,H. Zeidler,Joachim Sieper	150
8	Clinical response to withdrawal of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab (vol 7, pg R439, 2005) 2005 ·Arthritis Research ·Xenofon Baraliakos,Joachim Listing,J. Brandt,A. Zink,Rieke Alten,Gerd R Burmester,Erika Gromnica‐Ihle,Herbert Kellner,Matthias Schneider,H. Sörensen,(unknown),Martín Rudwaleit,Joachim Sieper,Juergen Braun	9
9	Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis 2004 ·Annals of the Rheumatic Diseases ·Joseph M. Braun,J. Brandt,Joachim Listing,A. Zink,Rieke Alten,Gerd R Burmester,Erika Gromnica‐Ihle,H. Kellner,M Schneider,H. Sörensen,H. Zeidler,Joachim Sieper	131
10	Six‐month results of a double‐blind, placebo‐controlled trial of etanercept treatment in patients with active ankylosing spondylitis 2003 ·Arthritis & Rheumatism ·J. Brandt,(unknown),Joachim Listing,Hildrun Haibel,H. Sörensen,(unknown),Martín Rudwaleit,Joachim Sieper,Jürgen Braun	359
11	Long‐term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: An open, observational, extension study of a three‐month, randomized, placebo‐controlled trial 2003 ·Arthritis & Rheumatism ·Jonathan Braun,J. Brandt,Joachim Listing,A. Zink,Rieke Alten,Gerd R Burmester,W. Golder,Erika Gromnica‐Ihle,H. Kellner,Matthias Schneider,H. Sörensen,H. Zeidler,(unknown),Joachim Sieper	192
12	The efficacy and safety of leflunomide in patients with active rheumatoid arthritis: A five‐year followup study 2003 ·Arthritis & Rheumatism ·Joachim R. Kalden,M Schattenkirchner,H. Sörensen,Paul Emery,Chris Deighton,Blaž Rozman,FC Breedveld	90
13	Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trialbreakdown → 2002 ·The Lancet ·Jürgen Braun,J. Brandt,Joachim Listing,A. Zink,Rieke Alten,W. Golder,(unknown),H. Kellner,Andreas Krause,Matthias Schneider,H. Sörensen,H. Zeidler,Wolfgang Thriene,Joachim Sieper	953
14	Frequency of triggering bacteria in patients with reactive arthritis and undifferentiated oligoarthritis and the relative importance of the tests used for diagnosis 2001 ·Annals of the Rheumatic Diseases ·C. Fendler,S Laitko,H. Sörensen,C Gripenberg-Lerche,A Groh,J Uksila,Kaisa Granfors,Jürgen Braun,J. Sieper	78
15	Therapie der ankylosierenden Spondylitis (AS) mit Radiumchlorid ( 224 SpondylAT®) 2001 ·Zeitschrift für Rheumatologie ·Jürgen Braun,E.‐M. Lemmel,Bernhard Manger,R. Rau,H. Sörensen,Joachim Sieper	14
16	Die Radiosynoviorthese im Behandlungsplan chronisch-entzündlicher Gelenkerkrankungen 1999 ·Zeitschrift für Rheumatologie ·(unknown),Karl‐Titus Hoffmann,H. Sörensen,D. Banzer	11
17	Differential surface expression of HLA-DRB1 and HLA-DRB4 among peripheral blood cells of DR4 positive individuals 1999 ·Human Immunology ·(unknown),Rieke Alten,Erika Gromnica‐Ihle,(unknown),Uwe Reuter,H. Sörensen,Brigitte Müller	18
18	Oral type II collagen treatment in early rheumatoid arthritis. A double‐blind, placebo‐controlled, randomized trial 1996 ·Arthritis & Rheumatism ·Joachim Sieper,S. Kary,H. Sörensen,Rieke Alten,U. Eggens,(unknown),Falk Hiepe,(unknown),Joachim Listing,Norbert Ulbrich,Jürgen Braun,A. Zink,N Mitchison	121
19	[Peroral norephedrine therapy of acute otitis media. A double-blind placebo-controlled study]. 1980 ·PubMed ·(unknown),Naja Dam Mygind,J. Thomsen,H. Sörensen,S. Vesterhauge	1
20	PERIPHERAL ARTERIAL EMBOLISM AND EMBOLECTOMY IN OLD AGE 1967 ·Journal of the American Geriatrics Society ·(unknown),(unknown),H. Sörensen	3

About H. Sörensen

H. Sörensen is a scholar working on Rheumatology, Hematology and Internal Medicine, having authored 25 papers that have together received 2.9k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (16 papers), Spondyloarthritis Studies and Treatments (14 papers) and Autoimmune and Inflammatory Disorders Research (5 papers). The work is most often cited by research in Rheumatology (2.4k citations), Hematology (948 citations) and Immunology (1.1k citations). H. Sörensen has collaborated with scholars based in Germany, Denmark and United States. Frequent co-authors include Joachim Sieper, Joachim Listing, J. Brandt, Jürgen Braun, H. Kellner, Rieke Alten, A. Zink, H. Zeidler, Matthias Schneider and W. Golder. Their work appears in journals such as The Lancet, Journal of the American Geriatrics Society and Annals of the Rheumatic Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact